Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). (Q44012393)
Jump to navigation
Jump to search
scientific article published in May 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). |
scientific article published in May 2002 |
Statements
1 reference
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). (English)
1 reference
1 reference
A Michael Lincoff
1 reference
Neal S Kleiman
1 reference
Elizabeth S Maierson
1 reference
Katherine E Wolski
1 reference
Kandace Kottke-Marchant
1 reference
Kelly Maresh
1 reference
1 May 2002
1 reference
1 reference
Identifiers
1 reference